- Current report filing (8-K)
May 10 2012 - 5:19PM
Edgar (US Regulatory)
United States
Securities and Exchange Commission
Washington, DC 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: May 4, 2012
GeneLink, Inc.
(Exact Name of Registrant as Specified in
its Charter)
PA
|
00-30518
|
23-2795613
|
(State or other Jurisdiction of
Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification
No.)
|
8240 Exchange Dr. Suite C1, Orlando,
FL 32809
(Address of Principal Executive Offices)
Registrant’s telephone number, including area code:
(800)
558-4363
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 4.02 NON-RELIANCE ON PREVIOUSLY ISSUED FINANCIAL STATEMENTS
OR A RELATED AUDIT REPORT OR COMPLETED INTERIM REVIEW.
On May 4, 2012, the Board of Directors of GeneLink, Inc. (the
“Company”), upon the recommendation of management after consulting with its independent auditors, concluded that the
Company’s financial statements for the year ended December 31, 2010 and the Company’s unaudited consolidated financial
statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2010, June 30, 2010, September
30, 2010, March 31, 2011, June 30, 2011, and September 30, 2011 could no longer be relied upon. The Company intends to file its
restated financial statements for the year ended December 31, 2010 in conjunction with the filing of the Company’s Annual
Report on Form 10-K for the year ended December 31, 2011.
A re-audit of 2010 was required when, on March 5, 2012, the
Company was notified that the Public Company Accounting Oversight Board (“PCAOB”) announced that it had suspended for
one year the registration of Buckno Lisicky & Company, P.C. (“Buckno”). Buckno, the company’s prior independent
registered accountants, was suspended for failure to timely file 2010 and 2011 annual reports with the PCAOB. As a result of that
suspension, the SEC determined that the Company could no longer include the audit reports of Buckno in its SEC filings. A re-audit
by a new firm was required to address 2010 comparative figures included in the 2011 Form 10-K filing, which is expected to be filed
on Friday, May 11, 2012.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit Number
|
Description
|
99.1
|
Press Release dated May 10,
2012
|
Signatures
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GeneLink, Inc.
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/ Bernard L. Kasten, Jr. M.D.
|
|
|
Bernard L. Kasten, Jr. M.D.
|
|
|
Chief Executive Officer
|
Dated: May 10, 2012
EXHIBIT INDEX
Exhibit Number
|
Description
|
99.1
|
Press Release dated May 10,
2012
|
GeneLink (CE) (USOTC:GNLKQ)
Historical Stock Chart
From Apr 2024 to May 2024
GeneLink (CE) (USOTC:GNLKQ)
Historical Stock Chart
From May 2023 to May 2024